Form 4: Forte Biosciences CFO Acquires Shares in Private Placement
SEC Form 4 Filing
Forte Biosciences' Chief Financial Officer, Antony A. Riley, purchased 22,514 shares of common stock in a private placement at $5.552 per share.
Summary
- Antony A. Riley, the Chief Financial Officer of Forte Biosciences, Inc., acquired 22,514 shares of common stock.
- The shares were purchased through a private placement at a price of $5.552 per share.
- The transaction was completed on November 21, 2024, following a Securities Purchase Agreement entered into on November 19, 2024.
- Following the transaction, Mr. Riley directly owns 30,776 shares of Forte Biosciences common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive as the CFO's purchase indicates confidence, but it's a routine transaction.
Positives
- The CFO's purchase of shares could be seen as a positive sign of confidence in the company's future.
Industry Context
This transaction is a routine filing related to insider trading and is not indicative of any broader industry trends.
Comparison to Industry Standards
- Insider purchases are common in the biotech industry, and this transaction is not unusual.
- The size of the purchase is relatively small compared to overall market capitalization of the company.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment due to the CFO's investment.
Key Dates
| Date | Description |
|---|---|
| 11/19/2024 | The Issuer and the Reporting Person entered into a Securities Purchase Agreement. |
| 11/21/2024 | The transaction contemplated by the Securities Purchase Agreement closed. |
| 11/22/2024 | The SEC Form 4 was signed and filed. |
Keywords
Forte Biosciences, Private Placement, Share Purchase, CFO, Antony A. Riley, Securities Purchase Agreement, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.